{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:07:28Z","timestamp":1785517648193,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40266-026-01316-7","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:05:08Z","timestamp":1784743508000},"page":"733-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Association Between Anticholinergic Burden and Treatment-Related Complications in Older Adults with Cancer"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-9678","authenticated-orcid":false,"given":"Edwin J.","family":"Brokaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-0528","authenticated-orcid":false,"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-6306","authenticated-orcid":false,"given":"Johanneke E. A.","family":"Portielje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-6246","authenticated-orcid":false,"given":"Loes E.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Mooijaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8427-8135","authenticated-orcid":false,"given":"Anna","family":"uit den Boogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8635-2581","authenticated-orcid":false,"given":"Joosje C.","family":"Baltussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6882-639X","authenticated-orcid":false,"given":"Yara","family":"van Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-3509","authenticated-orcid":false,"given":"Frederiek","family":"van den Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"1","key":"1316_CR1","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1316_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ijc.31664","volume":"144","author":"S Pilleron","year":"2019","unstructured":"Pilleron S, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144(1):49\u201358.","journal-title":"Int J Cancer"},{"issue":"9","key":"1316_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, et al. Annual report to the nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290\u2013314.","journal-title":"Cancer"},{"issue":"8","key":"1316_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101606","volume":"14","author":"EJ Brokaar","year":"2023","unstructured":"Brokaar EJ, et al. Medication optimization in older adults with advanced cancer and a limited life expectancy: a prospective observational study. J Geriatr Oncol. 2023;14(8):101606.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1316_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jgo.2020.06.013","volume":"12","author":"MG Miller","year":"2021","unstructured":"Miller MG, et al. Identifying potentially inappropriate medication (PIM) use in geriatric oncology. J Geriatr Oncol. 2021;12(1):34\u201340.","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"1316_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00520-014-2171-x","volume":"22","author":"JP Turner","year":"2014","unstructured":"Turner JP, et al. Prevalence and factors associated with polypharmacy in older people with cancer. Support Care Cancer. 2014;22(7):1727\u201334.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1634\/theoncologist.2019-0085","volume":"25","author":"S Hong","year":"2020","unstructured":"Hong S, et al. Polypharmacy, inappropriate medication use, and drug interactions in older Korean patients with cancer receiving first-line palliative chemotherapy. Oncologist. 2020;25(3):e502\u201311.","journal-title":"Oncologist"},{"issue":"4","key":"1316_CR8","first-page":"211","volume":"23","author":"G Nightingale","year":"2017","unstructured":"Nightingale G, Skonecki E, Boparai MK. The impact of polypharmacy on patient outcomes in older adults with cancer. Cancer J. 2017;23(4):211\u20138.","journal-title":"Cancer J"},{"issue":"3","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jgo.2012.02.005","volume":"3","author":"GK Prithviraj","year":"2012","unstructured":"Prithviraj GK, et al. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228\u201337.","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"1316_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/cncr.34642","volume":"129","author":"MR Mohamed","year":"2023","unstructured":"Mohamed MR, et al. Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer. Cancer. 2023;129(7):1096\u2013104.","journal-title":"Cancer"},{"issue":"12","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"e2170","DOI":"10.1002\/onco.13961","volume":"26","author":"LJ Chen","year":"2021","unstructured":"Chen LJ, et al. Association of polypharmacy with colorectal cancer survival among older patients. Oncologist. 2021;26(12):e2170\u201380.","journal-title":"Oncologist"},{"issue":"17","key":"1316_CR12","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1002\/cncr.34813","volume":"129","author":"DW Choi","year":"2023","unstructured":"Choi DW, et al. Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors. Cancer. 2023;129(17):2705\u201316.","journal-title":"Cancer"},{"issue":"1","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1186\/s12885-022-10026-3","volume":"22","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, et al. Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes. BMC Cancer. 2022;22(1):950.","journal-title":"BMC Cancer"},{"issue":"4","key":"1316_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jgo.2020.03.001","volume":"11","author":"G Lu-Yao","year":"2020","unstructured":"Lu-Yao G, et al. Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy. J Geriatr Oncol. 2020;11(4):579\u201385.","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s12885-023-10939-7","volume":"23","author":"H Pluchart","year":"2023","unstructured":"Pluchart H, et al. Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients. BMC Cancer. 2023;23(1):585.","journal-title":"BMC Cancer"},{"issue":"4","key":"1316_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11606-019-04837-7","volume":"34","author":"Y Schenker","year":"2019","unstructured":"Schenker Y, et al. Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness. J Gen Intern Med. 2019;34(4):559\u201366.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"1316_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.amjopharm.2007.10.001","volume":"5","author":"MW Bowie","year":"2007","unstructured":"Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5(3):263\u2013303.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"Suppl 21","key":"1316_CR18","first-page":"11","volume":"62","author":"LE Tune","year":"2001","unstructured":"Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(Suppl 21):11\u20134.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"1316_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101710","volume":"31","author":"A Al-Azayzih","year":"2023","unstructured":"Al-Azayzih A, et al. Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan. Saudi Pharm J. 2023;31(9):101710.","journal-title":"Saudi Pharm J"},{"issue":"36","key":"1316_CR20","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.2217\/fon-2021-0469","volume":"17","author":"AI Yasin","year":"2021","unstructured":"Yasin AI, et al. A comparison of anticholinergic burden in older patients with and without cancer. Future Oncol. 2021;17(36):5067\u201375.","journal-title":"Future Oncol"},{"issue":"8","key":"1316_CR21","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1007\/s00520-021-06008-z","volume":"29","author":"JH Lee","year":"2021","unstructured":"Lee JH, et al. Clinical outcomes associated with anticholinergic burden in older hospitalized patients with advanced cancer: a single-center database study. Support Care Cancer. 2021;29(8):4607\u201314.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1316_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12877-020-01975-0","volume":"21","author":"Y van Holstein","year":"2021","unstructured":"van Holstein Y, et al. Design and rationale of a routine clinical care pathway and prospective cohort study in older patients needing intensive treatment. BMC Geriatr. 2021;21(1):29.","journal-title":"BMC Geriatr"},{"issue":"7624","key":"1316_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"issue":"8","key":"1316_CR24","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166\u201372.","journal-title":"Ann Oncol"},{"issue":"7","key":"1316_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/gps.2776","volume":"27","author":"JP Tuijl","year":"2012","unstructured":"Tuijl JP, et al. Screening for cognitive impairment in older general hospital patients: comparison of the Six-Item Cognitive Impairment Test with the Mini-Mental State Examination. Int J Geriatr Psychiatry. 2012;27(7):755\u201362.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"1316_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"1316_CR27","unstructured":"ACB-Calculator. [cited 2026 April]. https:\/\/www.acbcalc.com\/. Accessed 24 Apr 2026."},{"issue":"10","key":"1316_CR28","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/jgs.13647","volume":"63","author":"JG Naples","year":"2015","unstructured":"Naples JG, et al. Concordance between anticholinergic burden scales. J Am Geriatr Soc. 2015;63(10):2120\u20134.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1316_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311\u201320.","journal-title":"Aging Health"},{"issue":"1","key":"1316_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12877-018-0929-6","volume":"18","author":"EK Kiesel","year":"2018","unstructured":"Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18(1):239.","journal-title":"BMC Geriatr"},{"issue":"6","key":"1316_CR31","first-page":"456","volume":"10","author":"B Vellas","year":"2006","unstructured":"Vellas B, et al. Overview of the MNA\u2014its history and challenges. J Nutr Health Aging. 2006;10(6):456\u2013663 (discussion 463-5).","journal-title":"J Nutr Health Aging"},{"issue":"12","key":"1316_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1532-5415.1983.tb03391.x","volume":"31","author":"S Katz","year":"1983","unstructured":"Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31(12):721\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1316_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179\u201386.","journal-title":"Gerontologist"},{"key":"1316_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020350","author":"M Santorsola","year":"2024","unstructured":"Santorsola M, et al. Exploring the spectrum of VEGF inhibitors\u2019 toxicities from systemic to intra-vitreal usage in medical practice. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16020350.","journal-title":"Cancers (Basel)"},{"key":"1316_CR35","unstructured":"US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. June 14, 2010. [cited 2022 Mar 31]. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"issue":"4","key":"1316_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/jgs.70327","volume":"74","author":"JC Baltussen","year":"2026","unstructured":"Baltussen JC, et al. How to analyze longitudinal patient-reported outcomes in populations with high mortality rates. J Am Geriatr Soc. 2026;74(4):1002\u201311.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1316_CR37","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/aje\/kwr458","volume":"175","author":"TJ VanderWeele","year":"2012","unstructured":"VanderWeele TJ, Hernan MA. Results on differential and dependent measurement error of the exposure and the outcome using signed directed acyclic graphs. Am J Epidemiol. 2012;175(12):1303\u201310.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"1316_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00520-023-07835-y","volume":"31","author":"MSR de Lima","year":"2023","unstructured":"de Lima MSR, et al. Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma. Support Care Cancer. 2023;31(7):379.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1316_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/10499091211003078","volume":"39","author":"EJ Brokaar","year":"2022","unstructured":"Brokaar EJ, et al. Deprescribing in older adults with cancer and limited life expectancy: an integrative review. Am J Hosp Palliat Care. 2022;39(1):86\u2013100.","journal-title":"Am J Hosp Palliat Care"},{"key":"1316_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010247","author":"A Moldasheva","year":"2024","unstructured":"Moldasheva A, Zhakupova A, Aljofan M. Antiproliferative mechanisms of metformin in breast cancer: a systematic review of the literature. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms26010247.","journal-title":"Int J Mol Sci"},{"key":"1316_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","volume":"71","author":"M Podhorecka","year":"2017","unstructured":"Podhorecka M, Ibanez B, Dmoszynska A. Metformin\u2014its potential anti-cancer and anti-aging effects. Postepy Hig Med Dosw (Online). 2017;71:170\u20135.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"11","key":"1316_CR42","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/0284186X.2018.1489144","volume":"57","author":"M Orum","year":"2018","unstructured":"Orum M, et al. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study. Acta Oncol. 2018;57(11):1458\u201366.","journal-title":"Acta Oncol"},{"key":"1316_CR43","unstructured":"Raza, S., et al. Assessment of frailty and risk of chemotherapy toxicity at a geriatric-oncology multidisciplinary clinic. R I Med J. 2023;106(4):13\u20138."},{"issue":"10314","key":"1316_CR44","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894\u2013904.","journal-title":"Lancet"},{"issue":"11","key":"1316_CR45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/phar.1843","volume":"36","author":"NL Campbell","year":"2016","unstructured":"Campbell NL, et al. Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population. Pharmacotherapy. 2016;36(11):1123\u201331.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1316_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65989-9","volume":"10","author":"N Cebron Lipovec","year":"2020","unstructured":"Cebron Lipovec N, Jazbar J, Kos M. Anticholinergic burden in children, adults and older adults in Slovenia: a nationwide database study. Sci Rep. 2020;10(1):9337.","journal-title":"Sci Rep"},{"issue":"1","key":"1316_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05394-3","volume":"24","author":"MA Mohammed","year":"2024","unstructured":"Mohammed MA, et al. Anticholinergic burden and frailty in older inpatients: insights from analysis of admission and discharge medicines using four anticholinergic scales. BMC Geriatr. 2024;24(1):1022.","journal-title":"BMC Geriatr"},{"issue":"2","key":"1316_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4140\/TCP.n.2021.104","volume":"36","author":"SD Rice","year":"2021","unstructured":"Rice SD, Kim N, Farris C. Anticholinergic cognitive burden in older people over acute admission. Sr Care Pharm. 2021;36(2):104\u201311.","journal-title":"Sr Care Pharm"},{"key":"1316_CR49","unstructured":"Medicine Use Statistics. Statistics Explained 2022 [cited 2025 10\/03]. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Medicine_use_statistics. Accessed Sept 2025."},{"issue":"3","key":"1316_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0269216309102528","volume":"23","author":"M Agar","year":"2009","unstructured":"Agar M, et al. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med. 2009;23(3):257\u201365.","journal-title":"Palliat Med"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01316-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01316-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:26:57Z","timestamp":1785515217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01316-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01316-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the appropriate institutional review board. The original study from which the data were extracted, was approved by an independent ethics committees and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participant provided written informed consent.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EB: conceptualization, data curation, formal analysis, methodology, project administration, and writing\u2014original draft; ST: conceptualization, data curation, methodology, and writing\u2014review and editing; LV: conceptualization, methodology, and writing\u2014review and editing; SM: writing\u2014review and editing; AudB: data collection and writing\u2014review and editing JB: data collection and writing\u2014review and editing; YvH: writing\u2014review and editing; FvdB: conceptualization, methodology, and writing\u2014review and editing; and JP: conceptualization, methodology, and writing\u2014review and editing. All authors read and approved the final manuscript and agree to be accountable for the work.","order":5,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings of this study are available from the corresponding author (EB) upon reasonable request.","order":6,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}